Soverini S; Martinelli G.; Rosti G.; Iacobucci I.; Baccarani M., Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis, «PHARMACOGENOMICS», 2012, 13, pp. 1271 - 1284 [Scientific article]
Concetta Quintarelli; Biagio De Angelis; Santa Errichiello; Simona Caruso; Nicola Esposito; Luigia Luciano; Simona Paratore; Claudia Galimberti; Simona Soverini; Carolina Terragna; Daniela Cilloni; Giuseppe Saglio; Giovanni Martinelli; Frank Giles; Andreas Hochhaus; Fabrizio Pane, Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib, in: Blood, «BLOOD», 2012, 120(21), pp. 2795 - 2795 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [Abstract]
Iacobucci I.; Ferrarini A.; Sazzini M.; Giacomelli E.; Lonetti A.; Xumerle L.; Ferrari A.; Papayannidis C.; Malerba G.; Luiselli D.; Boattini A.; Garagnani P.; Vitale A.; Soverini S.; Pane F.; Baccarani M.; Delledonne M.; Martinelli G., Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia, «BLOOD CANCER JOURNAL», 2012, 2, Article number: e61 , pp. 1 - 7 [Scientific article]Open Access
SOVERINI S.; GNANI A.; CATERINA DE BENEDITTIS C.; IACOBUCCI I.; VENTURI C.; PAPAYANNIDIS C.; LUPPI M.; MERANTE S.; MALAGOLA M.; RUSSO D.; TIRIBELLI M.; SALVUCCI M.; VITALE A.; ELIA L.; VIGNETTI M.; FOÀ R.; BACCARANI M.; MARTINELLI G., Bcr-Abl kinase domain mutations and resistance in Ph+ acute lymphoblastic leukemia from the imatinib to the 2nd-generation TKI era, in: JCO, «JOURNAL OF CLINICAL ONCOLOGY», 2012, 30(15), pp. 6531 - 6531 (atti di: 2012 ASCO Annual Meeting, Chicago, IL, June 1-5, 2012) [Abstract]
Abate F.; Acquaviva A.; Paciello G.; Foti C.; Ficarra E.; Ferrarini A.; Delledonne M.; Iacobucci I.; Soverini S.; Martinelli G.; Macii E., Bellerophontes: an RNA-Seq data analysis framework for chimeric transcripts discovery based on accurate fusion model, «BIOINFORMATICS», 2012, 28, pp. 2114 - 2121 [Scientific article]
Baccarani M.; Pileri S.; Steegmann J.L.; Muller M.; Soverini S; Dreyling M., Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, «ANNALS OF ONCOLOGY», 2012, 23 (suppl 7), pp. vii72 - vii77 [Scientific article]
White DL; Radich J; Soverini S; Saunders VA; Frede A; Dang P; Cilloni D; Lin P; Mongay L; Woodman R; Manley P; Slader C; Kim DW; Pane F; Martinelli G; Saglio G; Hughes TP., Chronic phase chronic myeloid leukemia patients with low OCT-1 activityrandomised to high-dose imatinib achieve better responses, and lower failure rates, than those randomized to standard-dose., «HAEMATOLOGICA», 2012, 97(6), pp. 907 - 914 [Scientific article]Open Access
Simona Soverini; Caterina De Benedittis; Katerina Machova Polakova; Adela Brouckova; Fausto Castagnetti; Cristina Papayannidis; Gabriele Gugliotta; Francesca Palandri; Hana Klamova; Ilaria Iacobucci; Claudia Venturi; Federica Cattina; Paola Bresciani; Valeria Coluccio; Marzia Salvucci; Mario Tiribelli; Gianni Binotto; Tamara Intermesoli; Mario Luppi; Maria Teresa Bochicchio; Emanuela Ottaviani; Domenico Russo; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli, Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications, in: Blood, «BLOOD», 2012, 120(21), pp. 692 - 692 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [Abstract]
Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Cristina Papayannidis, Gabriele Gugliotta, Francesca Palandri, Hana Klamova, Ilaria Iacobucci, Claudia Venturi, Federica Cattina, Paola Bresciani, Valeria Coluccio, Marzia Salvucci, Mario Tiribelli, Gianni Binotto, Tamara Intermesoli, Mario Luppi, Maria Teresa Bochicchio, Emanuela Ottaviani, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli, Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications, «BLOOD», 2012, 120, pp. 692 - 692 [Abstract]
I Iacobucci; D Erriquez; A Ferrari; C Papayannidis; C Venturi; S Trino; V Guadagnuolo; A Lonetti; F Cattina; E Ottaviani; M Abbenante; S Parisi; S Soverini; D Russo; F Pane; M Baccarani; G Perini; G Martinelli, Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia., in: Blood, «BLOOD», 2012, 120 (21), pp. 2522 - 2522 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 - 11, 2012) [Abstract]
Ilaria Iacobucci, Daniela Erriquez, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Stefania Trino, Viviana Guadagnuolo, Annalisa Lonetti, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Sarah Parisi, Simona Soverini, Domenico Russo, Fabrizio Pane, Michele Baccarani, Giovanni Perini, Giovanni Martinelli, Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia., «BLOOD», 2012, 120, pp. 2522 - 2522 [Abstract]
Intermesoli T.; Castagnetti F.; Soverini S.; Bussini A.; Spinelli O.; Gnani A.; Bassan R.; Rosti G., Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib., «LEUKEMIA RESEARCH», 2012, 36, pp. e10 - e11 [Scientific article]
G Gugliotta; F Castagnetti; F Palandri; M Breccia; L Levato; F Stagno; G Rege Cambrin; A Zaccaria; G Specchia; E Usala; A Gozzini; B Martino; A Capucci; I Pierri; M Tiribelli; M Bocchia; E Abruzzese; S Soverini; N Testoni; G Saglio; G Martinelli; F Pane; G Alimena; G Rosti; M Baccarani, EARLY PREDICTORS OF PROGRESSION TO ACCELERATED-BLASTIC PHASE IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 77 - 77 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [Abstract]
F Castagnetti; G Gugliotta; F Palandri; M Breccia; L Levato; F Stagno; G Specchia; G Rege Cambrin; L Luciano; A Gozzini; B Martino; A Capucci; T Intermesoli; M Tiribelli; M Cedrone; F Cavazzini; E Usala; S Soverini; N Testoni; F Pane; G Saglio; G Alimena; G Martinelli; G Rosti; M Baccarani., EUTOS SCORE IS PREDICTIVE FOR SURVIVAL AND OUTCOME IN PATIENTS WITH EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH NILOTINIB-BASED REGIMENS, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 76 - 76 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [Abstract]
Martinez-Serra J.; Gutiérrez A.; Marcús T.F.; Soverini S.; Amat J.C.; Navarro-Palou M.; Ros T.; Bex T.; Ballester C.; Bauça J.M.; Sanfelix S.; Novo A.; Vidal C.; Santos C.; Besalduch J., Four-channel asymmetric Real-Time PCR hybridization probe assay: a rapid pre-screening method for critical BCR-ABL kinase domain mutations., «CLINICAL BIOCHEMISTRY», 2012, 45, pp. 345 - 351 [Scientific article]
